Baxter International Inc.

NYSE:BAX Rapport sur les actions

Capitalisation boursière : US$17.0b

Baxter International Gestion

Gestion contrôle des critères 4/4

Le PDG Baxter International est Joe Almeida, nommé en Jan2016, a un mandat de 8.83 ans. La rémunération annuelle totale est $ 13.79M, composée du salaire de 9.4% et des bonus 90.6%, y compris les actions et options de la société. détient directement 0.11% des actions de la société, d'une valeur de $ 18.93M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 2.1 ans et 4.8 ans.

Informations clés

Joe Almeida

Directeur général

US$13.8m

Rémunération totale

Pourcentage du salaire du PDG9.4%
Durée du mandat du directeur général8.8yrs
Propriété du PDG0.1%
Durée moyenne d'occupation des postes de direction2.1yrs
Durée moyenne du mandat des membres du conseil d'administration4.8yrs

Mises à jour récentes de la gestion

Recent updates

Is Baxter International Inc. (NYSE:BAX) Trading At A 49% Discount?

Sep 05
Is Baxter International Inc. (NYSE:BAX) Trading At A 49% Discount?

Baxter- Reiterating Our Buy Rating After A Promising Q2

Aug 07

Baxter International (NYSE:BAX) Will Pay A Dividend Of $0.29

Aug 07
Baxter International (NYSE:BAX) Will Pay A Dividend Of $0.29

Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

Jul 23
Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

Baxter: Why Investors Should Take Advantage Of The Low Valuation

Jul 16

Little Excitement Around Baxter International Inc.'s (NYSE:BAX) Revenues

Jul 12
Little Excitement Around Baxter International Inc.'s (NYSE:BAX) Revenues

Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

May 30
Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29

Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29

May 14
Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29

Baxter International: Shares Too Cheap, EPS Growth Ahead With A Possible Spinoff

May 08

Capital Allocation Trends At Baxter International (NYSE:BAX) Aren't Ideal

Apr 14
Capital Allocation Trends At Baxter International (NYSE:BAX) Aren't Ideal

Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts

Feb 23

Baxter International's (NYSE:BAX) Dividend Will Be $0.29

Feb 20
Baxter International's (NYSE:BAX) Dividend Will Be $0.29

Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden

Jan 28
Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden

Baxter International (NYSE:BAX) Could Be Struggling To Allocate Capital

Jan 12
Baxter International (NYSE:BAX) Could Be Struggling To Allocate Capital

Baxter International Inc.'s (NYSE:BAX) Prospects Need A Boost To Lift Shares

Dec 28
Baxter International Inc.'s (NYSE:BAX) Prospects Need A Boost To Lift Shares

Baxter International: A Cheap Big Pharma Stock With Improving Earnings And +3% Dividend Yield

Dec 12

Estimating The Fair Value Of Baxter International Inc. (NYSE:BAX)

Nov 27
Estimating The Fair Value Of Baxter International Inc. (NYSE:BAX)

Is Baxter International (NYSE:BAX) A Risky Investment?

Oct 27
Is Baxter International (NYSE:BAX) A Risky Investment?

Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial?

Oct 12

There Are Reasons To Feel Uneasy About Baxter International's (NYSE:BAX) Returns On Capital

Sep 21
There Are Reasons To Feel Uneasy About Baxter International's (NYSE:BAX) Returns On Capital

Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29

Aug 23
Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29

Dividend Challengers Review: Baxter International

Aug 14

Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29

Jul 25
Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29

Baxter International (NYSE:BAX) Has A Somewhat Strained Balance Sheet

Jul 14
Baxter International (NYSE:BAX) Has A Somewhat Strained Balance Sheet

Baxter International: Hillrom Acquisition Could Be A Tailwind For FCF

Jun 12

Returns On Capital At Baxter International (NYSE:BAX) Paint A Concerning Picture

Jun 07
Returns On Capital At Baxter International (NYSE:BAX) Paint A Concerning Picture

Baxter International's (NYSE:BAX) Dividend Will Be $0.29

May 19
Baxter International's (NYSE:BAX) Dividend Will Be $0.29

Analyse de la rémunération des PDG

Comment la rémunération de Joe Almeida a-t-elle évolué par rapport aux bénéfices de Baxter International?
DateRémunération totaleSalaireBénéfices de l'entreprise
Sep 30 2024n/an/a

US$121m

Jun 30 2024n/an/a

US$98m

Mar 31 2024n/an/a

-US$38m

Dec 31 2023US$14mUS$1m

-US$76m

Sep 30 2023n/an/a

US$96m

Jun 30 2023n/an/a

-US$3b

Mar 31 2023n/an/a

-US$3b

Dec 31 2022US$14mUS$1m

-US$3b

Sep 30 2022n/an/a

-US$3b

Jun 30 2022n/an/a

US$876m

Mar 31 2022n/an/a

US$992m

Dec 31 2021US$16mUS$1m

US$1b

Sep 30 2021n/an/a

US$1b

Jun 30 2021n/an/a

US$1b

Mar 31 2021n/an/a

US$1b

Dec 31 2020US$16mUS$1m

US$1b

Sep 30 2020n/an/a

US$911m

Jun 30 2020n/an/a

US$924m

Mar 31 2020n/an/a

US$991m

Dec 31 2019US$14mUS$1m

US$1b

Sep 30 2019n/an/a

US$1b

Jun 30 2019n/an/a

US$1b

Mar 31 2019n/an/a

US$2b

Dec 31 2018US$16mUS$1m

US$2b

Sep 30 2018n/an/a

US$1b

Jun 30 2018n/an/a

US$795m

Mar 31 2018n/an/a

US$840m

Dec 31 2017US$15mUS$1m

US$609m

Rémunération vs marché: La rémunération totale de Joe ($USD 13.79M ) est dans la moyenne des entreprises de taille similaire sur le marché US ($USD 12.67M ).

Rémunération et revenus: La rémunération de Joe a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.


PDG

Joe Almeida (62 yo)

8.8yrs

Titularisation

US$13,786,671

Compensation

Mr. Jose E. Almeida, also known as Joe, has been the Chairman of the Board and Chief Executive Officer of Baxter International Inc. since January 1, 2016 and serves as its President since January 01, 2016....


Équipe de direction

NomPositionTitularisationCompensationPropriété
Jose Almeida
Chairman of the Board8.8yrsUS$13.79m0.11%
$ 18.9m
Joel Grade
Executive VP1.1yrsUS$5.37m0%
$ 0
Heather Knight
Executive VP & Group President of Medical Products and Therapies1.7yrsUS$4.86m0.031%
$ 5.3m
Alok Sonig
Executive VP & Group President of Pharmaceuticals2.3yrsUS$3.87m0.0024%
$ 400.2k
Christopher Toth
Executive VP & Group President of Kidney Care1.4yrsUS$9.64m0.0046%
$ 773.2k
Tobi Karchmer
Senior VP and Chief Medical & Scientific Officer1.8yrspas de donnéespas de données
Charles Patel
Senior VP & Chief Information Officerless than a yearpas de donnéespas de données
Clare Trachtman
Vice President of Investor Relationsno datapas de donnéespas de données
David Rosenbloom
Executive VP & General Counsel2.6yrsUS$5.66m0.0018%
$ 306.9k
Stacey Eisen
Senior Vice Presidentno datapas de donnéespas de données
Jeanne Mason
Executive VP & Chief Human Resources Officer7.5yrsUS$4.14m0.037%
$ 6.3m
James Borzi
Executive VP & Chief Supply Chain Officer4.8yrspas de données0.0036%
$ 608.7k

2.1yrs

Durée moyenne de l'emploi

54yo

Âge moyen

Gestion expérimentée: L'équipe de direction de BAX est considérée comme expérimentée (ancienneté moyenne 2.1 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Jose Almeida
Chairman of the Board8.8yrsUS$13.79m0.11%
$ 18.9m
Stephen Rusckowski
Independent Director1.3yrsUS$197.82k0.0018%
$ 301.8k
Robert Parkinson
Chairman Emeritus8.8yrsUS$17.88mpas de données
Peter Wilver
Independent Director2.5yrsUS$349.64k0.0026%
$ 440.9k
Stephen Newman Oesterle
Independent Director7.8yrsUS$373.98k0.0055%
$ 925.8k
Patricia Morrison
Independent Director5.8yrsUS$364.98k0.0042%
$ 708.8k
Nancy Schlichting
Independent Director2.9yrsUS$363.00k0.0028%
$ 474.8k
Catherine Smith
Independent Director7.8yrsUS$367.31k0.0044%
$ 749.5k
David Shafer
Lead Independent Director2.5yrsUS$382.31k0.0026%
$ 440.9k
David Wilkes
Independent Director3.8yrsUS$357.00k0.0032%
$ 540.9k
William Ampofo
Independent Director1.4yrsUS$226.35k0.0019%
$ 327.3k
Amy Wendell
Independent Director5.8yrsUS$352.98kpas de données

4.8yrs

Durée moyenne de l'emploi

66yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de BAX sont considérés comme expérimentés (ancienneté moyenne 4.8 ans).